Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2010
06/02/2010EP2190459A1 Use of cnp-22, alone1 or in combination with physalemin, as a therapeutic agent
06/02/2010EP2190456A2 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer
06/02/2010EP2190453A2 Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agents
06/02/2010EP2190452A2 Use of a peptide as a therapeutic agent
06/02/2010EP2190450A2 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents
06/02/2010EP1976397B1 Infant immunological formula
06/02/2010EP1830881B1 Combining therapies targeting multiple toll-like receptors and use thereof
06/02/2010EP1466914B1 Amorphous substance of tricyclic triazolobenzazepine derivative
06/02/2010EP1449432B1 Nonhuman model animal of systemic lupus erythematosus
06/02/2010EP1066050B2 Application of hsp70 proteins
06/02/2010CN201492710U Immunity regulation preparation structure
06/02/2010CN1965894B Prunella vulgaris polysaccharide having immune activity, preparation method and application thereof
06/02/2010CN1957927B Fat micro sphere preparation of triterpenoid saponin and derivative, and fabricating method
06/02/2010CN1938042B Use of aromatic cation peptide in preparing medicine for relieving oxidative damage
06/02/2010CN1826336B Cyclohexanecarboxylic acid compound
06/02/2010CN101720322A Compounds and compositions as c-kit and pdgfr kinase inhibitors
06/02/2010CN101717416A Derivative of alpha-amino phosphonic acid containing saccharide groups, preparation method and medical application thereof
06/02/2010CN101717410A Phosphorus-containing compounds & uses thereof
06/02/2010CN101717407A Highly substituted alpha-amino phosphonate derivative as well as preparation method and medical application thereof
06/02/2010CN101716346A Supramolecular hydrogel gene vector material, and preparation method and application thereof
06/02/2010CN101716335A Stable recombinant human interferon ointment
06/02/2010CN101716333A Preparation method of pupa glycoprotein immunoregulation preparation
06/02/2010CN101716326A Medicament for treating children chronic cough and allergic rhinitis and preparation method thereof
06/02/2010CN101716283A Method for constructing dendrobium officinale polysaccharide fingerprinting
06/02/2010CN101716279A Instant traditional Chinese medicine for refreshing spirit, nourishing Qi and building body
06/02/2010CN101716256A Preparation used for strengthening immunity and inhibiting tumor
06/02/2010CN101716240A Preparation for improving sleep, replenishing qi and promoting blood generation
06/02/2010CN101716221A Dripping pill for increasing leucocyte
06/02/2010CN101716215A Quality detection method of traditional Chinese medicine of isatis root
06/02/2010CN101716213A Traditional Chinese medicine effective fraction composition for detoxification and lipid lowering and preparation method thereof
06/02/2010CN101716199A Method for extracting flavonoids from leaves of cotton rose hibiscus
06/02/2010CN101716187A Oral liquid for promoting lead discharge and strengthening immunity and preparation method thereof
06/02/2010CN101716161A New thymosin chitosan microsphere type oral medicinal preparation and preparation method thereof
06/02/2010CN101716158A Method for preparing matrine slow-release tablet by applying attapulgite
06/02/2010CN101716140A Sea urchin rhizoma polygonati polysaccharide injection and preparation method thereof
06/02/2010CN101305975B Health preservation feet bath bag
06/02/2010CN101224215B Uses of ursolic acid saponin and oleanolic acid saponin in preparing medicine for increasing white blood cell and/or blood platelet
06/02/2010CN101167505B Selenium rich rabdosia rubescens tea
06/02/2010CN101152197B Compound glycyrrhizin dropping pills and method for preparing the same
06/02/2010CN101053370B Anti stress immunity enhancing agent for pig
06/01/2010US7728109 Antagonistic anti-hTNFSF13b human antibodies
06/01/2010US7728016 Substituted 5-membered ring compounds and their use
06/01/2010US7728014 Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist biological activity
06/01/2010US7727712 Having an immunostimulatory sequence comprising the sequence 5'-C, G-3', wherein an HBV antigen is not administered in conjunction with administration of said nucleotide; for treatment of subject with hepatitis B virus
06/01/2010CA2512040C Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection
06/01/2010CA2443456C Novel atisane compounds and use thereof
06/01/2010CA2440699C Compounds for treating inflammatory diseases
06/01/2010CA2423007C Spiro derivatives and adhesion molecule inhibitors containing the same as effective ingredients
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
06/01/2010CA2384064C Vaccine against herpes simplex virus and human papilloma virus
06/01/2010CA2358915C Modified hiv env polypeptides
06/01/2010CA2352524C Aromatic heterocyclic compounds as antiinflammatory agents
06/01/2010CA2332627C Porcine circovirus and parvovirus vaccine
05/2010
05/28/2010CA2645455A1 A method of medically treating an individual
05/27/2010WO2010060030A1 Tlr ligand-nucleic acid nanostructure as a novel immune modulatory agent and method of using the same
05/27/2010WO2010060026A1 Hiv/siv vaccines for the generation of mucosal and systemic immunity
05/27/2010WO2010059401A2 Compounds that expand hematopoietic stem cells
05/27/2010WO2010058846A1 4,6-diaminonicotinamide compound
05/27/2010WO2010058794A1 Antioxidant
05/27/2010WO2010057877A1 7-pyridinyl- or phenyl- substituted triazolo [1, 5 -a] pyridines as pi3k inhibitors
05/27/2010WO2010057447A1 Single-time vaccines
05/27/2010WO2010057275A1 Cyclic peptides and uses thereof
05/27/2010WO2010057251A1 Peptide conjugates for suppressing an immune response, methods of making and uses therefor
05/27/2010WO2010040096A3 Agonists of toll-like receptor 5 for the treatment of graft-versus-host disease
05/27/2010WO2010038155A3 Antibodies against il-25
05/27/2010WO2010031519A8 Transcutaneous compositions for specific immuno-modulatory treatment
05/27/2010WO2010017403A3 Therapeutic compositions, devices and methods for observing treated tissues
05/27/2010WO2010011347A3 Clip inhibitors and methods of modulating immune function
05/27/2010WO2010007376A3 Compositions monovalent for cd28 binding and methods of use
05/27/2010WO1990007321A3 Lymphocyte receptor homing sequences and their uses
05/27/2010US20100130729 Mu-1, member of the cytokine receptor family
05/27/2010US20100130598 Methods for inducing programmed cell death
05/27/2010US20100130596 Rad51 derived cancer cell specific promoters for targeted anti- cancer therapy
05/27/2010US20100130593 autoimmune or inflammatory diseases; multiple sclerosis, diabetes mellitus
05/27/2010US20100130592 RNA Interference Mediated Inhibition of GRB2 Associated Binding Protein (GAB2) Gene Expression Using Short Interfering Nucleic Acid (siNA)
05/27/2010US20100130584 Novel compounds from antrodia camphorata
05/27/2010US20100130533 Pharmaceutical creams with refined oleic acid
05/27/2010US20100130532 Reduction of imiquimod impurities in pharmaceutical creams
05/27/2010US20100130530 Reduction of imiquimod impurities using refined oleic acid
05/27/2010US20100130522 Compounds for inflammation and immune-related uses
05/27/2010US20100130518 Mapk/erk kinase inhibitors
05/27/2010US20100130510 Compounds for inflammation and immune-related uses
05/27/2010US20100130504 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/27/2010US20100130497 Therapeutic Compounds
05/27/2010US20100130496 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase
05/27/2010US20100130491 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7 ) modulators
05/27/2010US20100130469 2, 6-naphthridine derivatives
05/27/2010US20100130467 Triazolotriazines as kinase inhibitors
05/27/2010US20100130457 Phenothiazine Derivatives for Treatment of Asthma
05/27/2010US20100130408 Use of modified cyclosporins
05/27/2010US20100129438 Methods and Compositions for the Treatment and Prevention of HIV Infection Using TRIM5ALPHA
05/27/2010US20100129418 Method of inducing negative chemotaxis using an ellagitannin or gallotannin
05/27/2010US20100129404 Immediate protection against pathogens via mva
05/27/2010US20100129403 Recombinant viral vaccine
05/27/2010US20100129400 Attenuated viruses, vaccines and methods of use thereof
05/27/2010US20100129399 Linear expression constructs for production of influenza virus particles
05/27/2010US20100129389 Methods of modulating hvem, btla and cd160 cis complex response or signaling activity with soluble light polypeptide sequences
05/27/2010US20100129387 Pharmaceutical composition containing the nmb0606 protein
05/27/2010US20100129383 Bifunctional fusion molecules for the delivery of antigens to professional antigen-presenting cells
05/27/2010US20100129379 Stabilized antibody formulations and uses thereof
1 ... 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 ... 1172